#ITI#Effects of adaptation of infectious bronchitis virus arkansas attenuated vaccine to embryonic kidney cells#FTI#
#IRE#The population structure of an embryo-attenuated infectious bronchitis virus (IBV) Arkansas (Ark) Delmarva Poultry Industry (DPI)-derived vaccine was characterized during serial passages in chicken embryo kidney (CEK) cells and after back-passage in embryonated chicken eggs (ECE) and in chickens. Both conventional and deep-sequencing results consistently showed population changes occurred during adaptation to CEK cells. Specifically, 13 amino acid (aa) positions seemed to be targets of selection when comparing the vaccine genome prior to and after seven passages in CEK (CEKp7). Amino acid changes occurred at four positions in the spike (S) gene and, at two positions in the S gene, large shifts in frequencies of aa encoding were observed. CEK adaptation shifted the virus population towards homogeneity in S. The changes achieved in the S1 gene in CEKp7 were maintained after a back-passage in ECE. Outside the S gene, aa changes at three positions and large shifts in frequencies at four positions were observed. Synonymous nucleotide changes and changes in noncoding regions of the genome were observed at eight genome positions. Inoculation of early CEK passages into chickens induced higher antibody levels and CEKp4 induced increased respiratory signs compared to CEKp7. From an applied perspective, the fact that CEK adaptation of embryo-attenuated Ark vaccines reduces population heterogeneity, and that changes do not revert after one replication cycle in ECE or in chickens, provides an opportunity to improve commercial ArkDPI-derived vaccines. Â© American Association of Avian Pathologists.#FRE#
#IPC#Arkansas; coronavirus; genetic variation; infectious bronchitis virus; vaccine; virus adaptation#FPC#
#IRF#Ammayappan A., Upadhyay C., Gelb J., Vakharia V.N., Identification of sequence changes responsible for the attenuation of avian infectious bronchitis virus strain Arkansas DPI, Arch. Virol., 154, pp. 495-499, (2009); 
Armesto M., Cavanagh D., Britton P., The replicase gene of avian coronavirus infectious bronchitis virus is a determinant of pathogenicity, PLoS ONE, 4, (2009); 
Ballesteros M.L., Sanchez C.M., Enjuanes L., Two amino acid changes at the N-terminus of transmissible gastroenteritis coronavirus spike protein result in the loss of enteric tropism, Virology, 227, pp. 378-388, (1997); 
Baric R.S., Yount B., Hensley L., Peel S.A., Chen W., Episodic evolution mediates interspecies transfer of a murine coronavirus, J. Virol., 71, pp. 1946-1955, (1997); 
Casais R., Dove B., Cavanagh D., Britton P., Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism, J. Virol., 77, pp. 9084-9089, (2003); 
Cavanagh D., Severe acute respiratory syndrome vaccine development: Experiences of vaccination against avian infectious bronchitis coronavirus, Avian Pathol, 32, pp. 567-582, (2003); 
Cavanagh D., Davis P.J., Coronavirus IBV: Removal of spike glycopolypeptide S1 by urea abolishes infectivity and haemagglutination but not attachment to cells, J. Gen. Virol., 67, pp. 1443-1448, (1986); 
Cavanagh D., Davis P.J., Darbyshire J.H., Peters R.W., Coronavirus IBV: Virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection, J. Gen. Virol., 67, pp. 1435-1442, (1986); 
Cavanagh D., Mawditt K., Adzhar A., Gough R.E., Picault J.P., Naylor C.J., Haydon D., Shaw K., Britton P., Does IBV change slowly despite the capacity of the spike protein to vary greatly, Adv. Exp. Med. Biol., 440, pp. 729-734, (1998); 
Domingo E., Baranowski E., Ruiz-Jarabo C.M., Martin-Hernandez A.M., Saiz J.C., Escarmis C., Quasispecies structure and persistence of RNA viruses, Emerg. Infect. Dis., 4, pp. 521-527, (1998); 
Enjuanes L., Brian D., Cavanagh D., Holmes K., Lai M.M.C., Laude H., Masters P., Rottier P., Siddell S.G., Spaan W.J.M., Taguchi F., Talbot P., Coronaviridae, Virus Taxonomy. Classification and Nomenclature of Viruses, pp. 835-849, (2000); 
Enjuanes L., Spaan W.J., Snijder E.J., Cavanagh D., Nidovirales, Virus Taxonomy. Classification and Nomenclature of Viruses, pp. 827-834, (2000); 
Fang S.G., Shen S., Tay F.P., Liu D.X., Selection of and recombination between minor variants lead to the adaptation of an avian coronavirus to primate cells, Biochem. Biophys. Res. Comm., 336, pp. 417-423, (2005); 
Fazakerley J.K., Parker S.E., Bloom F., Buchmeier M.J., The V5A13. 1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system, Virology, 187, pp. 178-188, (1992); 
Gallardo R.A., Van Santen V.L., Toro H., Host intraspatial selection of infectious bronchitis virus populations, Avian Dis., 54, pp. 807-813, (2010); 
Hingley S.T., Gombold J.L., Lavi E., Weiss S.R., MHV-A59 fusion mutants are attenuated and display altered hepatotropism, Virology, 200, pp. 1-10, (1994); 
Jackwood M.W., Hilt D.A., Lee C.W., Kwon H.M., Callison S.A., Moore K.M., Moscoso H., Sellers H., Thayer S., Data from 11 years of molecular typing infectious bronchitis virus field isolates, Avian Dis., 49, pp. 614-618, (2005); 
Koch G., Hartog L., Kant A., Van Roozelaar D.J., Antigenic domains on the peplomer protein of avian infectious bronchitis virus: Correlation with biological functions, J. Gen. Virol., 71, pp. 1929-1935, (1990); 
Kusters J.G., Jager E.J., Lenstra J.A., Koch G., Posthumus W.P., Meloen R.H., Zeijst Der Van B.A., Analysis of an immunodominant region of infectious bronchitis virus, J. Immunol., 143, pp. 2692-2698, (1989); 
Kusters J.G., Niesters H.G., Bleumink-Pluym N.M., Davelaar F.G., Horzinek M.C., Zeijst Der Van B. A., Molecular epidemiology of infectious bronchitis virus in the Netherlands, J. Gen. Virol., 68, pp. 343-352, (1987); 
Kwon H.M., Jackwood M.W., Gelb J., Differentiation of infectious bronchitis virus serotypes using polymerase chain reaction and restriction fragment length polymorphism analysis, Avian Dis., 37, pp. 194-202, (1993); 
Lai M.M.C., Holmes K.V., Coronaviridae: The viruses and their replication, Lippincott Williams and Wilkins, pp. 641-663, (2001); 
Leparc-Goffart I., Hingley S.T., Chua M.M., Jiang X., Lavi E., Weiss S.R., Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein, Virology, 269, pp. 1-10, (1997); 
Li W., Zhang C., Sui J., Kuhn J.H., Moore M.J., Luo S., Wong S.K., Huang I.C., Xu K., Vasilieva N., Murakami A., He Y., Marasco W.A., Guan Y., Choe H., Farzan M., Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2, EMBO J., 24, pp. 1634-1643, (2005); 
McKinley E.T., Hilt D.A., Jackwood M.W., Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination, Vaccine, 26, pp. 1274-1284, (2008); 
Ndegwa E.N., Joiner K.S., Toro H., Van Ginkel F.W., Van Santen V.L., The proportion of specific viral subpopulations in attenuated ArkDPI infectious bronchitis vaccines influences vaccination outcome, Avian Dis., 56, pp. 642-653, (2012); 
Nix W.A., Troeber D.S., Kingham B.F., Keeler C.L., Gelb J., Emergence of subtype strains of the Arkansas serotype of infectious bronchitis virus in Delmarva broiler chickens, Avian Dis., 44, pp. 568-581, (2000); 
Ontiveros E., Kim T.S., Gallagher T.M., Perlman S., Enhanced virulence mediated by the murine coronavirus, mouse hepatitis virus strain JHM, is associated with a glycine at residue 310 of the spike glycoprotein, J. Virol., 77, pp. 10260-10269, (2003); 
Phillips J.E., Jackwood M.W., McKinley E.T., Thor S.W., Hilt D.A., Acevedol N.D., Williams S.M., Kissinger J.C., Paterson A.H., Robertson J.S., Lemke C., Changes in nonstructural protein 3 are associated with attenuation in avian coronavirus infectious bronchitis virus, Virus Genes, 44, pp. 63-74, (2012); 
Schat K.A., Purchase H.G., Cell-culture methods, A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp. 223-234, (1998); 
Sperry S.M., Kazi L., Graham R.L., Baric R.S., Weiss S.R., Denison M.R., Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice, J. Virol., 79, pp. 3391-3400, (2005); 
Toro H., Jackwood J.W., Van Santen V.L., Genetic diversity and selection regulates evolution of infectious bronchitis virus, Avian Dis., 56, pp. 449-455, (2012); 
Toro H., Lavaud P., Vallejos P., Ferreira A., Transfer of IgG from serum to lachrimal fluid in chickens, Avian Dis., 37, pp. 60-66, (1993); 
Toro H., Pennington D., Gallardo R.A., Van Santen V.L., Van Ginkel F.W., Zhang J.F., Joiner K.S., Infectious bronchitis virus subpopulations in vaccinated chickens after challenge, Avian Dis., 56, pp. 501-508, (2012); 
Toro H., Van Santen V.L., Li L., Lockaby S.B., Van Santen E., Hoerr F.J., Epidemiological and experimental evidence for immunodeficiency affecting avian infectious bronchitis, Avian Pathol., 35, pp. 1-10, (2006); 
Van Ginkel F.W., Van Santen V.L., Gulley S.L., Toro H., Infectious bronchitis virus in the chicken Harderian gland and lachrymal fluid: Viral load, infectivity, immune cell responses, and effects of viral immunodeficiency, Avian Dis., 52, pp. 608-617, (2008); 
Van Santen V.L., Thaxton G.E., Ndegwa E.N., Gallardo R.A., Toro H., ArkDPI-derived IBV vaccines and their subpopulations selected in chickens: Differences outside the S gene VII, International Symposium Avian Corona-and Pneumoviruses and Complicating Pathogens, pp. 94-97, (2012); 
Van Santen V.L., Toro H., Rapid selection in chickens of subpopulations within ArkDPI-derived infectious bronchitis virus vaccines, Avian Pathol., 37, pp. 293-306, (2008); 
Villegas P., Titration of biological suspensions, A Laboratory Manual for the Isolation, Identification and Characterization of Avian Pathogens, pp. 217-221, (2008); 
Wang G., Chen G., Zheng D., Cheng G., Tang H., PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type i interferon signaling pathway, PloS ONE, 6, (2011); 
Zheng D., Chen G., Guo B., Cheng G., Tang H., PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type i interferon production, Cell Res., 18, pp. 1105-1113, (2008); 
Zust R., Cervantes-Barragan L., Kuri T., Blakqori G., Weber F., Ludewig B., Thiel V., Coronavirus non-structural protein 1 is a major pathogenicity factor: Implications for the rational design of coronavirus vaccines, PLoS Pathog, 3, (2007)#FRF#
